2022 AUA preview: Dr. Schwen on top research in prostate cancer

Video

Zeyad Schwen, MD, highlights 5 studies in prostate cancer being presented at the 2022 American Urological Association Annual Meeting.

In this video, Zeyad Schwen, MD, discusses 5 studies in prostate cancer being presented at the 2022 American Urological Association Annual Meeting. Schwen is a urologist at the Glickman Urological & Kidney Institute, Cleveland Clinic.

The following 5 abstracts are previewed:

1. LBA01-01 (Basourakos et al): Harm-to-benefit of three decades of prostate cancer screening in Black men

2. PD03-01 (Robinsson et al): MRI as first investigation in men with elevated PSA. Population-based cohort study

3. LBA01-07 (Crawford et al): Overall safety and incidences of adverse events by time interval with darolutamide plus androgen-deprivation therapy and docetaxel in the phase 3 ARASENS trial

4. MP57-09 (Beksac et al): Comparison of Perioperative and Short-Term Functional Outcomes Between Single-Port Transvesical and Multi-Port Transperitoneal Robotic Radical Prostatectomy

5. PD17-11 (Checcucci et al): Comparison between target vs target plus standard biopsy for prostate cancer diagnosis in biopsy naive patients: a randomized controlled trial

Related Videos
Dr. Jasmeet Kaur in an interview with Urology Times
Dr. Martin Voss in an interview with Urology Times
Dr. Jacqueline Brown in an interview with Urology Times
blurred clinic hallway
Dr. Dalia Kaakour in an interview with red Urology Times backdrop
Dr. Maria Teresa Bourlon in an interview with Urology Times
Dr. David Braun in an interview with Urology Times
Dr. Neeraj Agarwal in an interview with Urology Times
Dr. Saby George in an interview with Urology Times
Dr. Laura Bukavina in an interview with Urology Times
Related Content
© 2024 MJH Life Sciences

All rights reserved.